Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment.
暂无分享，去创建一个
B. Melchior | Ch Lai | J. Hood | C. Barroga | Y. Yazici | M. Ibanez | B. Tam | L. Dellamary | S. Kc | C. Bossard | S. Anderson | V. Deshmukh | J. Tambiah | J. Cahiwat | T. Seo | S. Kennedy | K. Chiu | A. Ghias | R. Harris | A. O’green | L. Lamangan | L. Do | S. Cho | M. Pedraza | R. Harris